2024
Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 : A Binational Cohort Study.
Kim M, Lee H, Lee S, Kwon R, Rhee S, Lee J, Koyanagi A, Smith L, Fond G, Boyer L, Lee J, Rahmati M, Shin J, Min C, Shin J, Yon D. Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 : A Binational Cohort Study. Annals Of Internal Medicine 2024, 177: 291-302. PMID: 38437702, DOI: 10.7326/m23-1831.Peer-Reviewed Original ResearchConceptsAutoimmune inflammatory rheumatic diseasesUninfected control patientsInfluenza infectionControl patientsSARS-CoV-2 infectionHistory of COVID-19Acute COVID-19Uninfected patientsSeverity of acute COVID-19Severe acute COVID-19Associated with increased riskSARS-CoV-2Follow-up periodInflammatory rheumatic diseasesClaims-based databaseLong-term riskMatched index datePropensity score matchingJapanese patientsIndex dateMatched patientsCohort studyJapanese cohortPrimary outcomeIncreased risk
2021
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, Soma VL, Maddux AB, Mourani PM, Bowens C, Maamari M, Hall MW, Riggs BJ, Giuliano JS, Singh AR, Li S, Kong M, Schuster JE, McLaughlin GE, Schwartz SP, Walker TC, Loftis LL, Hobbs CV, Halasa NB, Doymaz S, Babbitt CJ, Hume JR, Gertz SJ, Irby K, Clouser KN, Cvijanovich NZ, Bradford TT, Smith LS, Heidemann SM, Zackai SP, Wellnitz K, Nofziger RA, Horwitz SM, Carroll RW, Rowan CM, Tarquinio KM, Mack EH, Fitzgerald JC, Coates BM, Jackson AM, Young CC, Son MBF, Patel MM, Newburger JW, Randolph AG. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA 2021, 325: 1074-1087. PMID: 33625505, PMCID: PMC7905703, DOI: 10.1001/jama.2021.2091.Peer-Reviewed Original ResearchConceptsMultisystem inflammatory syndromeOrgan system involvementInflammatory syndromeCase seriesSystem involvementCardiorespiratory involvementCOVID-19Positive severe acute respiratory syndrome coronavirus 2Higher C-reactive protein levelsPositive RT-PCR test resultsSevere acute respiratory syndrome coronavirus 2Severe acute COVID-19Acute respiratory syndrome coronavirus 2C-reactive protein levelsSevere coronavirus disease 2019Left ventricular systolic functionRT-PCR test resultsRespiratory syndrome coronavirus 2Organ system complicationsAcute COVID-19Coronary artery aneurysmsVentricular systolic functionLow platelet countAntibody test resultsIntensive care unit
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply